Literature DB >> 2055337

The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

G Perriello1, P De Feo, E Torlone, C Fanelli, F Santeusanio, P Brunetti, G B Bolli.   

Abstract

In 114 subjects with Type 1 (insulin-dependent) diabetes mellitus the nocturnal insulin requirements to maintain euglycaemia were assessed by means of i.v. insulin infusion by a Harvard pump. The insulin requirements decreased after midnight to a nadir of 0.102 +/- 0.03 mU.kg-1.min-1 at 02.40 hours. Thereafter, the insulin requirements increased to a peak of 0.135 +/- 0.06 mU.kg-1.min-1 at 06.40 hours (p less than 0.05). The dawn phenomenon (increase in insulin requirements by more than 20% after 02.40 hours lasting for at least 90 min) was present in 101 out of the 114 diabetic subjects, and its magnitude (% increase in insulin requirements between 05.00-07.00 hours vs that between 01.00-03.00 hours) was 19.4 +/- 0.54% and correlated inversely with the duration of diabetes (r = -0.72, p less than 0.001), but not with age. The nocturnal insulin requirements and the dawn phenomenon were highly reproducible on three separate nights. In addition, glycaemic control, state of counterregulation to hypoglycaemia and insulin sensitivity all influenced the magnitude of the dawn phenomenon as follows. In a subgroup of 84 subjects with Type 1 diabetes, the multiple correlation analysis showed that not only duration of diabetes (t = -9.76, p less than 0.0001), but also % HbA1 significantly influenced the magnitude of the dawn phenomenon (t = 2.03, p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055337     DOI: 10.1007/bf00404020

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  46 in total

1.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

Authors:  E A McGuire; J H Helderman; J D Tobin; R Andres; M Berman
Journal:  J Appl Physiol       Date:  1976-10       Impact factor: 3.531

2.  Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusion.

Authors:  J J Bending; J C Pickup; A C Collins; H Keen
Journal:  Diabetes Care       Date:  1985 Jan-Feb       Impact factor: 19.112

3.  Alterations in insulin clearance and hepatic blood flow during the night do not contribute to the 'dawn phenomenon' in type 1 diabetes.

Authors:  A Widmer; U Keller; M Pasquel; W Berger
Journal:  Horm Res       Date:  1988

4.  Fasting early morning rise in peripheral insulin: evidence of the dawn phenomenon in nondiabetes.

Authors:  M I Schmidt; Q X Lin; J T Gwynne; S Jacobs
Journal:  Diabetes Care       Date:  1984 Jan-Feb       Impact factor: 19.112

5.  Effects of free fatty acids, insulin, glucagon and adrenaline on ketone body production in humans.

Authors:  J M Miles; M W Haymond; J E Gerich
Journal:  Ciba Found Symp       Date:  1982

6.  Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitus.

Authors:  P J Campbell; J E Gerich
Journal:  Diabetes       Date:  1986-07       Impact factor: 9.461

7.  Dawn phenomenon: its frequency in non-insulin-dependent diabetic patients on conventional therapy.

Authors:  J A Atiea; R R Ryder; J Vora; D R Owens; S D Luzio; S Williams; T M Hayes
Journal:  Diabetes Care       Date:  1987 Jul-Aug       Impact factor: 19.112

8.  Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.

Authors:  G Bolli; P De Feo; G Perriello; S De Cosmo; P Compagnucci; F Santeusanio; P Brunetti; R H Unger
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Pump-induced insulin aggregation. A problem with the Biostator.

Authors:  J R Brennan; S S Gebhart; W G Blackard
Journal:  Diabetes       Date:  1985-04       Impact factor: 9.461

10.  In search of the Somogyi effect.

Authors:  E A Gale; A B Kurtz; R B Tattersall
Journal:  Lancet       Date:  1980-08-09       Impact factor: 79.321

View more
  14 in total

1.  Within-patient variation of the pharmacokinetics of subcutaneously injected biphasic insulin aspart as assessed by compartmental modelling.

Authors:  W H O Clausen; A De Gaetano; A Vølund
Journal:  Diabetologia       Date:  2006-07-25       Impact factor: 10.122

2.  The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day.

Authors:  Roberto Visentin; Enrique Campos-Náñez; Michele Schiavon; Dayu Lv; Martina Vettoretti; Marc Breton; Boris P Kovatchev; Chiara Dalla Man; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2018-02-16

3.  Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII).

Authors:  Michael A Nauck; Anna M Lindmeyer; Chantal Mathieu; Juris J Meier
Journal:  J Diabetes Sci Technol       Date:  2019-10-21

4.  Detection of Insulin Pump Malfunctioning to Improve Safety in Artificial Pancreas Using Unsupervised Algorithms.

Authors:  Lorenzo Meneghetti; Gian Antonio Susto; Simone Del Favero
Journal:  J Diabetes Sci Technol       Date:  2019-10-14

Review 5.  Advances in diabetes for the millennium: insulin treatment and glucose monitoring.

Authors:  Daniel Einhorn
Journal:  MedGenMed       Date:  2004-09-16

6.  A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing.

Authors:  Allen B King; Dana U Armstrong
Journal:  J Diabetes Sci Technol       Date:  2007-01

7.  A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing.

Authors:  Allen B King; Dana U Armstrong
Journal:  J Diabetes Sci Technol       Date:  2007-01

8.  Both acute and chronic near-normoglycaemia are required to improve insulin resistance in type 1 (insulin-dependent) diabetes mellitus.

Authors:  P Fasching; K Ratheiser; P Damjancic; B Schneider; P Nowotny; H Vierhapper; W Waldhäusl
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

9.  Dynamic insulin on board: incorporation of circadian insulin sensitivity variation.

Authors:  Chiara Toffanin; Howard Zisser; Francis J Doyle; Eyal Dassau
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

10.  Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency.

Authors:  P J Boyle; A Avogaro; L Smith; S D Shah; P E Cryer; J V Santiago
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.